April 27, 2020
Crestone secures NIH cash for antibiotic vs. H. pylori
Crestone, Inc. today announced a grant award from the National Institutes of Health for the preclinical evaluation of its antibiotic candidate CRS3123 to treat infections caused by Helicobacter pylori.